Pfizer mulls sale of animal health business; hires J.P. Morgan to evaluate alternatives - DVM
  • SEARCH:
News Center
DVM Featuring Information from:

ADVERTISEMENT

Pfizer mulls sale of animal health business; hires J.P. Morgan to evaluate alternatives

DVM360 MAGAZINE

New York — Pfizer may sell its animal-health business, the company reports.

The move, according to Pfizer, would be made to “determine the optimal mix of businesses for maximizing shareholder value.”

Pfizer officials are considering a full or partial separation of its animal-health and nutrition businesses through a spin-off, sale or other transaction. The U.S.-based drugmaker hired J.P. Morgan to evaluate strategic alternatives for its animal-health business. And it expects to complete "any transactions that may result from these evaluations in 12 to up to 24 months," the company says in a prepared statement.

"Given the separate and distinct nature of Animal Health and Nutrition, the company may pursue a different strategic alternative for each business," Pfizer says. Pfizer Animal Health operates in more than 60 countries. In 2010, animal-health revenues were estimated at about $3.6 billion.

"The actions we're announcing today are driven by the potential to create value for shareholders and enable Pfizer to become a more focused organization, better positioned for future success," says Pfizer's president and chief executive officer Ian Read. "Ultimately, our decisions will continue to support our long-term strategy to allocate our resources, investments and people to the areas that best serve our patients and customers, and generate the best value for our shareholders," Read says.

ADVERTISEMENT

Source: DVM360 MAGAZINE,
Click here